Raju Prasad, CFO: Crispr Therapeutics CRSP Sell · Filed 01/08

Trade details

Type: Insider sale
Amount: $1,139,387.94
Shares · price: 18,933 sh · $60.18 a share
Held after: 17,534 sh
Stock: Crispr Therapeutics CRSP
Person: Raju PrasadCFO
Trade date: 26/01/06
Filed: 26/01/08
Days to filing: 2 days

Sold 51.9% of holdings

Share of holding sold: 51.9%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/07~02/05

Raju Prasad's recent trades

Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$173.5K
3,708 sh
$173.5K
Filed 03/24
Traded 03/23
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$282.2K
5,848 sh
$282.2K
Filed 03/17
Traded 03/16
Raju PrasadCFO
SellCrispr Therapeutics
Sell
Crispr Therapeutics
CRSP
$194.1K
4,021 sh
$194.1K
Filed 03/17
Traded 03/16
Raju PrasadCFO
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/26
Traded 01/22
Raju PrasadCFO
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 plan
Crispr Therapeutics
CRSP
$2.1M
34,972 sh
$2.1M
Filed 01/22
Traded 01/22

Raju Prasad, CFO — sold $1.1M of Crispr Therapeutics CRSP · 51.9% of holdings · 10b5-1 plan | Whalegun